What is Quibim?
Quibim operates at the forefront of medical imaging analysis, providing a comprehensive whole-body imaging ecosystem known as Quibim Precision®. This platform is utilized globally by leading research institutions for diverse applications, including disease detection and monitoring the efficacy of novel therapeutic treatments. By adopting an AI-first methodology, Quibim aims to enhance diagnostic accuracy and accelerate medical research through the development of quantitative imaging biomarkers, addressing a critical need for precise and comprehensive health assessments.
How much funding has Quibim raised?
Quibim has raised a total of $50M across 1 funding round:
Series A
$50M
Series A (2025): $50M with participation from GoHub Ventures, UI Investissement, and Asabys Partners
Key Investors in Quibim
GoHub Ventures
GoHub Ventures is an early-stage venture capital fund that invests in founders developing B2B software and digital health solutions. They provide long-term capital and hands-on support, focusing on sectors such as artificial intelligence, operational efficiency, and preventive care.
UI Investissement
UI Investissement helps small and medium businesses grow across France. They work with privately held companies at every stage of their journey, providing smart money and support to help businesses reach their full potential.
Asabys Partners
Asabys Partners is an investment firm based in Barcelona that focuses on fostering breakthrough innovation in healthcare and life sciences. The firm invests in highly innovative and transformative technologies, aiming to improve patients' lives through disruptive advancements in science and medicine.
What's next for Quibim?
The recent major strategic investment signals Quibim's transition into a scaling phase, likely focusing on expanding its market reach and further developing its AI-driven imaging analysis capabilities. This Series A capital will empower the company to enhance its product offerings, potentially broaden its global partnerships, and solidify its position as an innovator in the medical imaging technology sector. The company's focus on AI and quantitative biomarkers suggests a strategic direction towards precision medicine and advanced diagnostic solutions.
See full Quibim company page
